SP1 and Alzheimer disease: We found that Sp1, a downstream effector overexpressed in AD, binds the ACSL4 promoter to drive the conversion of PUFAs into peroxidation-prone lipids (Li et al., 2019a; Long and Holtzman, 2019; Zhang et al., 2019; Liu et al., 2020).